Is Pharma Poised for a Powerful Rebound? Chart Master Sees a Major Breakout Ahead
Unpacking the Final Trades: GDX, Pfizer, GlobalFoundries, and Bristol Myers Squibb Under the Microscope
The Enduring Battle: Trump, Pfizer, and the Shifting Tides of Prescription Drug Pricing
Trump's Pfizer Deal: A 'Devastating' Blow to PBMs and Insurers, Warns LaMattina
The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer
Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway
Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead
RFK Jr.'s Vaccine Panel Set to Ignite New Debate on COVID-19 Shot Guidance
Healthcare's Pulse Check: Why High-Yield Dividends Might Be Your Best Bet in a Struggling Sector